Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Clinical and Molecular Hepatology
>
2019
>
25
>
1
Volume:
25
Issue:
1
1. Biochemical profile in an infant with neonatal hemochromatosis shows evidence of impairment of mitochondrial long-chain fatty acid oxidation
Page:86—91
2. Safety margin of embolized area can reduce local recurrence of hepatocellular carcinoma after superselective transarterial chemoembolization
Page:74—85
3. Efficacy of L-carnitine on ribavirin-induced hemolytic anemia in patients with hepatitis C virus infection
Page:65—73
4. Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
Page:52—64
5. Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
Page:42—51
6. Can hepatic steatosis really promote hepatitis B viral hepatocarcinogenesis? The jury is out on.
Page:40—41
7. Biomarker microfibril-associated glycoprotein 4 for non-invasive diagnosis and therapeutic evaluation of hepatic fibrosis in patients with hepatitis C
Page:37—39
8. Discussion on critical points for a tailored therapy to cure hepatitis C virus infection
Page:30—36
9. Radiomics and radiogenomics of primary liver cancers
Page:21—29
10. Pathologic differential diagnosis of metastatic carcinoma in the liver
Page:12—20
11. Recent research trends and updates on nonalcoholic fatty liver disease
Page:1—11